Fundraising Fox

Alex Leech

Investor

Partner, Biovelocita Strategy at Sofinnova Partners

London, England, United Kingdom

About

Alex Leech is a Partner at Sofinnova Partners and CEO of Forth Therapeutics. He has founded biotechnology companies and has experience in fundraising and mergers and acquisitions.

Experience

  1. Forth TherapeuticsCEOcurrent2024 β€” present
  2. Sofinnova PartnersPartnercurrent2023 β€” presentLondon, United Kingdom
  3. Sevenless TherapeuticsChaircurrent2020 β€” presentGreater London, England, United Kingdom
  4. Ensocell Therapeutics LtdChair2023 β€” 2026Cambridge, England, United Kingdom
  5. Bicycle TherapeuticsEIR2021 β€” 2023Cambridge, England, United Kingdom
  6. 2N PharmaChair2021 β€” 2023Denmark
  7. SV Health InvestorsVenture Partner2019 β€” 2021London Area, United Kingdom
  8. AlchemabCEO2019 β€” 2021Cambridge, England, United Kingdom
  9. Zarodex TherapeuticsCEO2017 β€” 2020London, United Kingdom
  10. Camphos TherapeuticsCEO2017 β€” 2019Cambridge
  11. Creabilis SACEO2015 β€” 2017UK / Italy / Luxembourg
  12. Creabilis SAChief Operating Officer2010 β€” 2015UK / Italy / Luxembourg
  13. Solace Pharmaceuticals Inc.Executive Director, Head of Operations2007 β€” 2010Cambridge, MA & UK
  14. PfizerProject Management Group Head2003 β€” 2007Global R&D

Education

  1. Henley Business SchoolM.B.A, Business2000 β€” 2003
  2. University of SussexBEng, Mechanical Engineering1991 β€” 1995

Skills & more

Biotechnology6Strategy2Operations Management1Corporate Finance1Pharmaceutical Industry13Project Management3Clinical Research1Clinical Development4LifesciencesClinical Trials6R&D1New Business Development
+6 moreProduct DevelopmentOutsourcingAutomotiveEngineeringLean ManufacturingSix Sigma

From Alex's professional profile.

Colleagues at Sofinnova Partners

Agnès Pauquet
Head of Human Resources at Sofinnova Partners
Ahmed Fourati
Investor Relations and Reporting Officer at Sofinnova Partners
Aishwarya Parthasarathy
Associate, Digital Medicine Strategy at Sofinnova Partners
Alexandra Abreu
Analyst, Crossover Strategy at Sofinnova Partners
Andrew M. Weiss
Venture Partner at Sofinnova Partners
Anis Belmili
Fund Accountant at Sofinnova Partners
Ankeet Jethwa
Senior Associate, Capital Strategy at Sofinnova Partners
Anna Belousova
Associate, Industrial Biotech Strategy at Sofinnova Partners

Frequently asked questions

Where does Alex Leech work?
Alex Leech is Partner, Biovelocita Strategy at Sofinnova Partners.

Same school

Also attended Henley Business School34

John HortonInvestor at DN CapitalIrene ArdenstedtInvestor at Luminar VenturesCharles VasletSenior Partner, Chief Revenue Officer at Emerald Technology Ventures AgSanne van ErpInvestment manager at NoaberKieran MudryyPartner at 4BIO CapitalDavid LeftleyCo Founder & CTO at Bloc Ventures

+ 28 more

Also attended University of Sussex52

Hamish GarnettAssociate at Manta Ray VenturesMolly CookeTeam Assistant at NorthzoneJackson HeddyCFO at NorthzoneGeorgia AbbottAssociate Director at Marlin Equity PartnersSimon SegarsExecutive Advisor at Black Opal VenturesMehmet AkalinExperts | Venture Partner at 212

+ 46 more

Shared employers

Also worked at Bicycle Therapeutics3

Michael AnsteyPartner at Cambridge Innovation CapitalAnja KoenigGlobal Head of NVF at Novartis Venture FundCatherine StaceVP - Strategic Relationships at O2h Ventures

Also worked at SV Health Investors26

Victoria TaylorInvestor at MedicxiAmy SlizofskiInvestor at TRANSFORMATION CAPITALAlexander Sinclair-Wilsonζ‰§θ‘Œθ‘£δΊ‹ at Qiming Venture PartnersPaul LaVioletteManaging Partner at SV Health InvestorsGregory MaddenManaging Partner at SV Health InvestorsEugene HillChairman at SV Health Investors

+ 20 more

Also worked at Alchemab3

Alex Badamchi-ZadehVice President at SV Health InvestorsOlivia CavlanPartner at LifeArc VenturesMichael GillespieSenior Associate at RA Capital

Also worked at Pfizer143

Jigar RaythathaInvestor at Third Rock VenturesAbbie CelnikerInvestor at Third Rock VenturesJeb KeiperInvestor at Third Rock VenturesRichard ChesworthInvestor at Third Rock VenturesBriggs MorrisonEntrepreneur Partner at MPM BioImpactJohn McKearnSenior Advisor at RiverVest Venture Partners, focused on early-stage biotech

+ 137 more